
    
      The purpose of this trial is to gather data on the safety and effectiveness of the Contour
      /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial
      aneurysms for submission to FDA in support of a premarket approval application for the
      device. This trial is a prospective, multicenter single-arm study. Up to 220 subjects will be
      enrolled at up to 20 participating investigational sites.
    
  